Clinical Trials · NCT00308438
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Shire
- Enrollment
- 67
- Start date
- Mar 2004
- Locations
- 24 sites, United States, Canada
- Primary endpoint
- The percentage of subjects who are in remission (CDAI score less than 150) at week 12 of this study.